Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its Spikevax 2025-2026 formula, targeting the SARS-CoV-2 ...

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.

ID Solutions will produce and supply dPCR assays for use in non-clinical research on Qiagen's QIAcuity platforms.

The FDA has approved Nucala (mepolizumab) as an add-on maintenance treatment for certain COPD patients whose disease isn't ...

The ultrasound catheter is being tested in the PreVail-PH2 study, an early feasibility trial enrolling PH patients with left ...

View online. YOUR MORNING May 23, 2025 Good morning, NewsNation. For more fact-based, unbiased news coverage 24/7 – Download ...